Table 1

Participant characteristics

HV (n=10)DLE (n=9)SCLE (n=1)
Age (years), mean (SD)55.7 (5.4)56.0 (12.0)58.0 (NC)
Female, n (%)5 (50)7 (78)1 (100)
Body mass index (kg/m2), mean (SD)28.1 (6.2)28.1 (4.4)35.1 (NC)
Race, n (%)
 American Indian or Alaskan Native1 (10)00
 Asian000
 Black or African-American03 (33)0
 White9 (90)6 (67)1 (100)
Concomitant SLE per ACR criteria, nN/A30
Concomitant medication, n (%)07 (78)1 (100)
 Hydroxychloroquine05 (56)1 (100)
 Prednisone02 (22)0
 Corticosteroid NOS03 (33)0
 Clobetasol propionate02 (22)0
 Fluocinonide01 (11)0
 Hydrocortisone000
 Mycophenolate mofetil01 (11)1 (100)
 Tacrolimus001 (100)
Disease activity
 PGA (mm), mean (range)N/A13.3 (10–30)20
 CLASI-A, mean (range)N/A11.8 (4–19)11
  • ACR, American College of Rheumatology; CLASI-A, Cutaneous Lupus Area and Severity Index-activity; DLE, discoid lupus erythematosus; HV, healthy volunteer; N/A, not applicable; NC, not calculable; NOS, not otherwise specified; PGA, Physician Global Assessment; SCLE, subacute cutaneous lupus erythematosus.